Squaric acid dibutyl ester by Squarex Pharmaceutical for Herpes Labialis (Oral Herpes): Likelihood of Approval

Squaric acid dibutyl ester is under clinical development by Squarex Pharmaceutical and currently in Phase I for Herpes Labialis (Oral Herpes).

Study shows favorable response to app-based cancer pain management for children

A recent study led by Assistant Professor Lindsay Jibb of the Lawrence Bloomberg Faculty of Nursing and Scientist at The Hospital for Sick Children (SickKids)

February 20, 2024

Crunching the numbers: assessing Hungary’s reluctance towards entomophagy

Study explores the rate of insect consumption in Hungary over the five years between 2016 and 2021.

July 4, 2023

U.K. Doc Admits Trying to Kill Mother’s Partner With Poison Disguised as COVID Vax

LONDON — A British doctor on Monday admitted to trying to kill his mother’s long-term partner, who stood between him and an inheritance, by injecting

October 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.